These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15603794)

  • 1. The effect of the physical form of poly(lactic-co-glycolic acid) carriers on the humoral immune response to co-delivered antigen.
    Bennewitz NL; Babensee JE
    Biomaterials; 2005 Jun; 26(16):2991-9. PubMed ID: 15603794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-encapsulation of an antigen and CpG oligonucleotides into PLGA microparticles by TROMS technology.
    San Román B; Irache JM; Gómez S; Tsapis N; Gamazo C; Espuelas MS
    Eur J Pharm Biopharm; 2008 Sep; 70(1):98-108. PubMed ID: 18501572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral immune responses to model antigen co-delivered with biomaterials used in tissue engineering.
    Matzelle MM; Babensee JE
    Biomaterials; 2004 Jan; 25(2):295-304. PubMed ID: 14585717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time course study of the antigen-specific immune response to a PLGA microparticle vaccine formulation.
    Wang Q; Tan MT; Keegan BP; Barry MA; Heffernan MJ
    Biomaterials; 2014 Sep; 35(29):8385-93. PubMed ID: 24986256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface modification of poly(D,L-lactic-co-glycolic acid) nanoparticles with protamine enhanced cross-presentation of encapsulated ovalbumin by bone marrow-derived dendritic cells.
    Han R; Zhu J; Yang X; Xu H
    J Biomed Mater Res A; 2011 Jan; 96(1):142-9. PubMed ID: 21105162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodegradable nanoparticle delivery of a Th2-biased peptide for induction of Th1 immune responses.
    Lutsiak ME; Kwon GS; Samuel J
    J Pharm Pharmacol; 2006 Jun; 58(6):739-47. PubMed ID: 16734975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of agarose and poly(lactic-co-glycolic acid) on dendritic cell maturation.
    Yoshida M; Babensee JE
    J Biomed Mater Res A; 2006 Nov; 79(2):393-408. PubMed ID: 16886225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors effecting the Th2-like immune response after gamma-irradiation: low production of IL-12 heterodimer in antigen-presenting cells and small expression of the IL-12 receptor in T cells.
    Park HR; Jo SK; Paik SG
    Int J Radiat Biol; 2005 Mar; 81(3):221-31. PubMed ID: 16019931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination.
    Wang D; Molavi O; Lutsiak ME; Elamanchili P; Kwon GS; Samuel J
    J Pharm Pharm Sci; 2007; 10(2):217-30. PubMed ID: 17706180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of poly(lactic-co-glycolic acid) contact on maturation of murine bone marrow-derived dendritic cells.
    Yoshida M; Mata J; Babensee JE
    J Biomed Mater Res A; 2007 Jan; 80(1):7-12. PubMed ID: 16958042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An ovalbumin-IL-12 fusion protein is more effective than ovalbumin plus free recombinant IL-12 in inducing a T helper cell type 1-dominated immune response and inhibiting antigen-specific IgE production.
    Kim TS; DeKruyff RH; Rupper R; Maecker HT; Levy S; Umetsu DT
    J Immunol; 1997 May; 158(9):4137-44. PubMed ID: 9126973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo evidence of oral vaccination with PLGA nanoparticles containing the immunostimulant monophosphoryl lipid A.
    Sarti F; Perera G; Hintzen F; Kotti K; Karageorgiou V; Kammona O; Kiparissides C; Bernkop-Schnürch A
    Biomaterials; 2011 Jun; 32(16):4052-7. PubMed ID: 21377204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly(L-lactic-co-glycolic acid) scaffold.
    Jeon O; Song SJ; Kang SW; Putnam AJ; Kim BS
    Biomaterials; 2007 Jun; 28(17):2763-71. PubMed ID: 17350678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent, long lasting systemic antibody levels and mixed Th1/Th2 immune response after nasal immunization with malaria antigen loaded PLGA microparticles.
    Carcaboso AM; Hernández RM; Igartua M; Rosas JE; Patarroyo ME; Pedraz JL
    Vaccine; 2004 Mar; 22(11-12):1423-32. PubMed ID: 15063565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limiting dilution analysis of CD4 T-cell cytokine production in mice administered native versus polymerized ovalbumin: directed induction of T-helper type-1-like activation.
    Gieni RS; Yang X; Kelso A; Hayglass KT
    Immunology; 1996 Jan; 87(1):119-26. PubMed ID: 8666423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of oral tolerance in the primed immune system: influence of antigen persistence and adjuvant form.
    Leishman AJ; Garside P; Mowat AM
    Cell Immunol; 2000 Jun; 202(2):71-8. PubMed ID: 10896766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen.
    Slütter B; Bal S; Keijzer C; Mallants R; Hagenaars N; Que I; Kaijzel E; van Eden W; Augustijns P; Löwik C; Bouwstra J; Broere F; Jiskoot W
    Vaccine; 2010 Aug; 28(38):6282-91. PubMed ID: 20638455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quillaja saponin can modulate ovalbumin-induced IgE allergic responses through regulation of Th1/Th2 balance in a murine model.
    Katayama S; Mine Y
    J Agric Food Chem; 2006 May; 54(9):3271-6. PubMed ID: 16637684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Pathogen-mimicking" nanoparticles for vaccine delivery to dendritic cells.
    Elamanchili P; Lutsiak CM; Hamdy S; Diwan M; Samuel J
    J Immunother; 2007; 30(4):378-95. PubMed ID: 17457213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposome fusogenicity and entrapment efficiency of antigen determine the Th1/Th2 bias of antigen-specific immune response.
    Brgles M; Habjanec L; Halassy B; Tomasić J
    Vaccine; 2009 Sep; 27(40):5435-42. PubMed ID: 19632317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.